Designing Biodegradable Wafers Based on Poly(L-lactide-co-glycolide) and Poly(glycolide-co-ε-caprolactone) for the Prolonged and Local Release of Idarubicin for the Therapy of Glioblastoma Multiforme

PURPOSE: The blood-brain barrier limits the application of idarubicin in the therapy of glioblastoma multiforme. Biodegradable, intracranial wafers with prolonged release may increase therapy efficiency. METHODS: Blank wafers, wafers containing 5% w/w and 10% w/w of idarubicin were formulated by sol...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Pharm Res
Autori principali: Turek, Artur, Stoklosa, Katarzyna, Borecka, Aleksandra, Paul-Samojedny, Monika, Kaczmarczyk, Bożena, Marcinkowski, Andrzej, Kasperczyk, Janusz
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer US 2020
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7205781/
https://ncbi.nlm.nih.gov/pubmed/32382838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11095-020-02810-2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi